|
Cash Flow for
Savient Pharmaceuticals Inc.
(SVNT)
|
|
|
|
|
|
|
| Cash Flow |
in Thousands of Dollars |
|
|
| Net Income |
(118,312) |
(102,027) |
(73,109) |
(90,853) |
(84,169) |
| Depreciation |
448 |
392 |
418 |
471 |
474 |
| Amortization |
13,082 |
9,659 |
4,374 |
2,661 |
- |
| Amortization of Intagibles |
- |
- |
- |
- |
- |
| Deferred Income Taxes |
- |
(22,717) |
- |
- |
(642) |
| Operating Gains/Losses |
(21,800) |
9 |
- |
(182) |
889 |
| Extraordinary Gains/Losses |
- |
- |
- |
- |
- |
| Decrease in Receivables |
396 |
(3,828) |
1,449 |
3,990 |
3,779 |
| Decrease in Inventories |
6,599 |
(7,784) |
(2,555) |
1,307 |
744 |
| Decrease in Prepaid Expenses |
(6) |
(1,079) |
(1,013) |
1,380 |
323 |
| Decrease in Other Current Assets |
- |
- |
- |
- |
- |
| Increase in Payables |
(3,611) |
5,445 |
(6,314) |
2,027 |
1,836 |
| Increase in Other Current Liabilities |
2,140 |
6,582 |
3,550 |
(4,612) |
3,251 |
| Decrease in Other Working Capital |
1,736 |
(6,071) |
616 |
(378) |
(847) |
| Other Non-Cash Items |
17,665 |
14,242 |
20,217 |
14,544 |
9,898 |
| Net Cash from Continuing Operations |
(114,745) |
(116,836) |
(52,367) |
(69,645) |
(64,464) |
| Net Cash from Discontinued Operations |
- |
- |
- |
- |
- |
| Cash from Operating Activities |
(114,745) |
(116,836) |
(52,367) |
(69,645) |
(64,464) |
|
|
| Sale of Property, Plant, Equipment |
- |
- |
- |
- |
- |
| Sale of Long Term Investments |
- |
- |
- |
- |
- |
| Sale of Short Term Investments |
66,450 |
30,413 |
13,348 |
4,170 |
13,516 |
| Purchase of Property, Plant, Equipment |
(1,678) |
(416) |
(234) |
(71) |
(268) |
| Acquisitions |
- |
- |
- |
- |
644 |
| Purchase of Long Term Investments |
- |
- |
- |
- |
- |
| Purchase of Short Term Investments |
(56,705) |
(66,038) |
(33,417) |
(25) |
(323) |
| Other Investment Changes, Net |
- |
- |
- |
10 |
(25) |
| Cash from Investing Activities |
8,217 |
(37,341) |
(20,303) |
4,084 |
13,544 |
| Cash from Discontinued Investing Activities |
- |
- |
- |
- |
- |
|
| Issuance of Debt |
42,647 |
222,697 |
- |
- |
- |
| Issuance of Capital Stock |
502 |
803 |
10,631 |
97,484 |
2,637 |
| Repayment of Debt |
- |
- |
- |
(66) |
- |
| Repurchase of Capital Stock |
- |
- |
(1,282) |
- |
(208) |
| Payment of Cash Dividends |
- |
- |
- |
- |
- |
| Other Financing Charges, Net |
- |
(35) |
(60) |
- |
(59) |
| Cash from Financing Activities |
43,149 |
223,465 |
9,289 |
97,418 |
2,370 |
| Cash from Discontinued Financing Activities |
- |
- |
- |
- |
- |
|
|
| Effect of Exchange Rate Changes |
(383) |
15 |
- |
- |
- |
| Net Change in Cash |
(63,762) |
69,303 |
(63,381) |
31,857 |
(48,550) |
|
| Cash at Beginning of Year |
114,094 |
44,791 |
108,172 |
76,315 |
124,865 |
| Cash at End of Period |
50,332 |
114,094 |
44,791 |
108,172 |
76,315 |
| Foreign Sales |
- |
- |
- |
- |
N/A |
| Domestic Sales |
- |
- |
- |
- |
N/A |
|
|
|
